A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Clinical trial NCT07137598 · RECRUITING
Trial details
- NCT number
- NCT07137598
- Sponsor
- Hoffmann-La Roche
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-05
- Primary completion
- 2027-04-19
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.